Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial
However, a local drastic lowering or prolonged depression of glutathione under pathogenic conditions could gradually induce neuronal damage
The central cellular energy sensor, AMP-activated protein kinase (AMPK) has been demonstrated to have both synergistic and antagonistic impacts on luteal steroidogenesis
GHK-Cus tissue repair profile does support connective tissue healing, tendon and ligament structure, and the anti-inflammatory environment that acute and chronic injury recovery requires
Caution should be taken with those that have megaloblastic anemia as B12 can reduce potassium levels in the blood
IV therapy is safe for first-time patients when administered by a licensed medical professional